KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Pfizer (PFE) Enterprise Value (2016 - 2025)

Pfizer (PFE) has disclosed Enterprise Value for 17 consecutive years, with -$13.3 billion as the latest value for Q4 2025.

  • Quarterly Enterprise Value rose 34.12% to -$13.3 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$13.3 billion through Dec 2025, up 34.12% year-over-year, with the annual reading at -$13.3 billion for FY2025, 34.12% up from the prior year.
  • Enterprise Value for Q4 2025 was -$13.3 billion at Pfizer, up from -$14.7 billion in the prior quarter.
  • The five-year high for Enterprise Value was -$6.8 billion in Q2 2024, with the low at -$44.5 billion in Q3 2023.
  • Average Enterprise Value over 5 years is -$21.8 billion, with a median of -$19.9 billion recorded in 2023.
  • The sharpest move saw Enterprise Value crashed 186.88% in 2021, then soared 84.67% in 2024.
  • Over 5 years, Enterprise Value stood at -$30.8 billion in 2021, then increased by 27.04% to -$22.5 billion in 2022, then soared by 44.76% to -$12.4 billion in 2023, then plummeted by 62.56% to -$20.2 billion in 2024, then surged by 34.12% to -$13.3 billion in 2025.
  • According to Business Quant data, Enterprise Value over the past three periods came in at -$13.3 billion, -$14.7 billion, and -$12.9 billion for Q4 2025, Q3 2025, and Q2 2025 respectively.